Salient Surgical Technologies, developer of advanced energy devices for use in surgical procedures, announced the completion of its Series F financing totaling $17.9 million. Investors in the round included Piper Jaffray, Arnerich Massena & Associates, Medtronic, Inc., RiverVest Venture Partners, and other financial and strategic investors.
Salient plans to use the net proceeds to fund programs aimed at continuing to expand its sales and marketing organization and accelerating development of new advanced energy products based on its proprietary Transcollation™ technology. Salient will also use a portion of the proceeds to fund working capital requirements and amortize term debt.
Salient Surgical Technologies, Inc. Secures $17.9 Million in Series F Financing Round
-(Via Business Wire Health News.)
![Reblog this post [with Zemanta]](http://img.zemanta.com/reblog_e.png?x-id=d813967d-0c4b-4963-b84f-6c940170f85c)
Theoretically Related Posts
Eben is a highly caffeinated business development associate at a small, cash sensitive pharmaceutical company somewhere in Massachusetts. He enjoys cliche-less banter, compartmentalization, non-equilibrium thermodynamics and NPV analysis. Agree or disagree with what he's posted? He encourages comments.
If one were so inclined, one could follow him at any of these fine web 2.0 establishments:
Feel free to leave a comment below. Eben loves comments. You may also subscribe to comments through this RSS Comments feed or trackback here.
Add New Comment
Thanks. Your comment is awaiting approval by a moderator.
Do you already have an account? Log in and claim this comment.
Add New Comment
Trackbacks
(Trackback URL)